vs

Side-by-side financial comparison of Privia Health Group, Inc. (PRVA) and Symbotic Inc. (SYM). Click either name above to swap in a different company.

Symbotic Inc. is the larger business by last-quarter revenue ($630.0M vs $541.2M, roughly 1.2× Privia Health Group, Inc.). Privia Health Group, Inc. runs the higher net margin — 1.7% vs 0.4%, a 1.3% gap on every dollar of revenue. On growth, Symbotic Inc. posted the faster year-over-year revenue change (29.4% vs 17.4%). Over the past eight quarters, Symbotic Inc.'s revenue compounded faster (21.9% CAGR vs 14.2%).

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

Symbotic Inc. is an American robotics warehouse automation company based in Wilmington, Massachusetts.

PRVA vs SYM — Head-to-Head

Bigger by revenue
SYM
SYM
1.2× larger
SYM
$630.0M
$541.2M
PRVA
Growing faster (revenue YoY)
SYM
SYM
+12.0% gap
SYM
29.4%
17.4%
PRVA
Higher net margin
PRVA
PRVA
1.3% more per $
PRVA
1.7%
0.4%
SYM
Faster 2-yr revenue CAGR
SYM
SYM
Annualised
SYM
21.9%
14.2%
PRVA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PRVA
PRVA
SYM
SYM
Revenue
$541.2M
$630.0M
Net Profit
$9.2M
$2.6M
Gross Margin
21.2%
Operating Margin
2.1%
1.0%
Net Margin
1.7%
0.4%
Revenue YoY
17.4%
29.4%
Net Profit YoY
108.0%
174.9%
EPS (diluted)
$0.08
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRVA
PRVA
SYM
SYM
Q4 25
$541.2M
$630.0M
Q3 25
$580.4M
$618.5M
Q2 25
$521.2M
$592.1M
Q1 25
$480.1M
$549.7M
Q4 24
$460.9M
$486.7M
Q3 24
$437.9M
$503.6M
Q2 24
$422.3M
$491.9M
Q1 24
$415.2M
$424.3M
Net Profit
PRVA
PRVA
SYM
SYM
Q4 25
$9.2M
$2.6M
Q3 25
$6.9M
$-3.6M
Q2 25
$2.7M
$-5.9M
Q1 25
$4.2M
$-3.9M
Q4 24
$4.4M
$-3.5M
Q3 24
$3.5M
$-2.5M
Q2 24
$3.5M
$-2.5M
Q1 24
$3.0M
$-6.6M
Gross Margin
PRVA
PRVA
SYM
SYM
Q4 25
21.2%
Q3 25
20.6%
Q2 25
18.2%
Q1 25
19.6%
Q4 24
16.4%
Q3 24
12.7%
Q2 24
13.7%
Q1 24
10.4%
Operating Margin
PRVA
PRVA
SYM
SYM
Q4 25
2.1%
1.0%
Q3 25
2.5%
-3.5%
Q2 25
0.6%
-6.2%
Q1 25
1.1%
-5.8%
Q4 24
1.1%
-5.1%
Q3 24
1.3%
-4.3%
Q2 24
1.2%
-5.1%
Q1 24
0.2%
-12.0%
Net Margin
PRVA
PRVA
SYM
SYM
Q4 25
1.7%
0.4%
Q3 25
1.2%
-0.6%
Q2 25
0.5%
-1.0%
Q1 25
0.9%
-0.7%
Q4 24
1.0%
-0.7%
Q3 24
0.8%
-0.5%
Q2 24
0.8%
-0.5%
Q1 24
0.7%
-1.6%
EPS (diluted)
PRVA
PRVA
SYM
SYM
Q4 25
$0.08
$0.02
Q3 25
$0.05
$-0.04
Q2 25
$0.02
$-0.05
Q1 25
$0.03
$-0.04
Q4 24
$0.03
$-0.03
Q3 24
$0.03
$-0.03
Q2 24
$0.03
$-0.02
Q1 24
$0.02
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRVA
PRVA
SYM
SYM
Cash + ST InvestmentsLiquidity on hand
$479.7M
$1.8B
Total DebtLower is stronger
Stockholders' EquityBook value
$737.2M
$663.8M
Total Assets
$1.4B
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRVA
PRVA
SYM
SYM
Q4 25
$479.7M
$1.8B
Q3 25
$441.4M
$1.2B
Q2 25
$390.1M
$777.6M
Q1 25
$469.3M
$954.9M
Q4 24
$491.1M
$903.0M
Q3 24
$422.0M
$727.3M
Q2 24
$387.4M
$870.5M
Q1 24
$351.1M
$901.4M
Stockholders' Equity
PRVA
PRVA
SYM
SYM
Q4 25
$737.2M
$663.8M
Q3 25
$709.1M
$221.3M
Q2 25
$682.9M
$210.8M
Q1 25
$659.4M
$205.4M
Q4 24
$635.2M
$196.5M
Q3 24
$614.9M
$197.2M
Q2 24
$595.4M
$418.7M
Q1 24
$576.8M
$417.1M
Total Assets
PRVA
PRVA
SYM
SYM
Q4 25
$1.4B
$3.0B
Q3 25
$1.4B
$2.4B
Q2 25
$1.3B
$1.8B
Q1 25
$1.2B
$2.0B
Q4 24
$1.1B
$1.7B
Q3 24
$1.1B
$1.6B
Q2 24
$1.1B
$1.6B
Q1 24
$1.0B
$1.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRVA
PRVA
SYM
SYM
Operating Cash FlowLast quarter
$127.5M
$191.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
13.93×
73.61×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRVA
PRVA
SYM
SYM
Q4 25
$127.5M
$191.5M
Q3 25
$52.0M
$530.7M
Q2 25
$8.0M
$-138.3M
Q1 25
$-24.1M
$269.6M
Q4 24
$74.8M
$205.0M
Q3 24
$33.2M
$-99.4M
Q2 24
$34.5M
$50.4M
Q1 24
$-33.1M
$21.1M
Free Cash Flow
PRVA
PRVA
SYM
SYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$197.7M
Q3 24
$-120.1M
Q2 24
$33.5M
Q1 24
$18.6M
FCF Margin
PRVA
PRVA
SYM
SYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
40.6%
Q3 24
-23.9%
Q2 24
6.8%
Q1 24
4.4%
Capex Intensity
PRVA
PRVA
SYM
SYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.5%
Q3 24
4.1%
Q2 24
3.4%
Q1 24
0.6%
Cash Conversion
PRVA
PRVA
SYM
SYM
Q4 25
13.93×
73.61×
Q3 25
7.58×
Q2 25
2.97×
Q1 25
-5.70×
Q4 24
17.00×
Q3 24
9.38×
Q2 24
9.94×
Q1 24
-11.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRVA
PRVA

FFS Patient Care$364.4M67%
Capitated Revenue$71.4M13%
Shared Savings$46.9M9%
FFS Administrative Services$36.0M7%
Care Management Fee PMPM$20.0M4%
Other Revenue$2.5M0%

SYM
SYM

Systems$590.3M94%
Operation Services$28.8M5%
Software Maintenance And Support$10.9M2%
Revision Of Prior Period Change In Accounting Principle Adjustment$2.9M0%
Related Party$1.1M0%

Related Comparisons